Changes in Retinal Neovascularization after Pegaptanib (Macugen) Therapy in Diabetic Individuals
- 31 January 2006
- journal article
- Published by Elsevier BV in Ophthalmology
- Vol. 113 (1), 23-28
- https://doi.org/10.1016/j.ophtha.2005.10.012
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular EdemaOphthalmology, 2005
- Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good visionOphthalmology, 2003
- VEGF164-mediated Inflammation Is Required for Pathological, but Not Physiological, Ischemia-induced Retinal NeovascularizationThe Journal of Experimental Medicine, 2003
- The effect of a growth hormone receptor antagonist drug on proliferative diabetic retinopathyOphthalmology, 2001
- Spontaneous Regression of Neovascularization at the Disk and Elsewhere in Diabetic RetinopathyAmerican Journal of Ophthalmology, 1996
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersNew England Journal of Medicine, 1994
- Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 1994
- The Wisconsin Epidemiologic Study of Diabetic RetinopathyAmerican Journal of Ophthalmology, 1984
- The Wisconsin Epidemiologic Study of Diabetic RetinopathyAmerican Journal of Ophthalmology, 1984
- Preliminary Report on Effects of Photocoagulation TherapyAmerican Journal of Ophthalmology, 1976